New Ideas and New Treatment Options for Acquired Resistance for ALK_ROS1 [360p]
Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved or are currently undergoing scientific review. In this video, Dr. Owoni...
Author: cancergrace
Added: 03/23/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts